ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2026)
ImmunityBio (IBRX) reported Exchange Rate Effect of $122000.0 for Q1 2026, up 1320.0% year-over-year from $8591.5 in Q1 2025, and up 2340.0% quarter-over-quarter from $5000.0 in Q4 2025.
ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 7 years of Exchange Rate Effect data on file, last reported at $122000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $122000.0, up 1320.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $147000.0 (up 2350.0% YoY), and the FY2025 annual result was $15000.0, up 165.22% from the prior year.
- Exchange Rate Effect rose to $122000.0 in Q1 2026 per IBRX's latest filing, from $5000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $255000.0 in Q2 2022 and troughed at -$254000.0 in Q1 2023.
- A 5-year average of $6235.3 and a median of -$1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect plunged 609.09% in 2025, then soared 1320.0% in 2026.
- A 5-year view of Exchange Rate Effect shows it stood at $161000.0 in 2022, then plunged by 116.77% to -$27000.0 in 2023, then surged by 74.07% to -$7000.0 in 2024, then jumped by 171.43% to $5000.0 in 2025, then surged by 2340.0% to $122000.0 in 2026.
- Business Quant data shows IBRX's Exchange Rate Effect at $122000.0 in Q1 2026, $5000.0 in Q4 2025, and -$56000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | 122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |